Authors
Latest:
Dean Celia reflects on 40th anniversary of Dermatology TimesDean Celia, our original managing editor, reflects the beginning of Dermatology Times and the medical editors, Dr. Ronald Wheeland and Dr. Norman Levine, who ensured the publication focused on the key industry developments that mattered most to practicing dermatologists.
Latest:
Rosacea Recap: Comparing Treatment OptionsJames Q. Del Rosso, DO, highlights different rosacea treatment options in his session at the 2022 Fall Clinical Dermatology Conference for PAs & NPs.
Latest:
Creative initiative involves clinicians in innovationDrs. Lilit Garibyan, Steve Xu and Kachiu C. Lee highlight a grassroots initiative that encourages physicians to become more involved in innovation in dermatology.
Latest:
Creative initiative involves clinicians in innovationDrs. Lilit Garibyan, Steve Xu and Kachiu C. Lee highlight a grassroots initiative that encourages physicians to become more involved in innovation in dermatology.
Latest:
IL-17 potential therapeutic target for pustular psoriasisResearchers performed a systematic review of available reports on the therapeutic benefit of interleukin (IL)-17/T-helper 17 (Th17) axis inhibitors in patients with generalized pustular psoriasis (GPP). Read what they discovered in this article.
Latest:
AI: It’s not dermatologist vs. machineIn this month's Innovation article, Steve Xu, M.D., FAAD, highlights a company and innovator who are using artificial intelligence to augment physician decision-making, not replace it.
Latest:
Ultrasound technology may be useful treatment for rosaceaDrs. López and Kaufman discuss two new studies that examine the use of ultrasound technology as a new modality for treatment of erythematotelangiectatic and refractory rosacea.
Latest:
Clinical Pearls for Superficial and Medium Depth Chemical PeelsHarold J. Brody, MD, provides his best tips and tricks for superficial and medium depth chemical peels in a presentation at the 2022 ASDS Annual Meeting.
Latest:
DTC compounded medications: A treatment option for a system in need?How should dermatologists feel about direct-to-consumer online companies compounding prescription formulations? Read from three experts on the topic in this article.
Latest:
DTC compounded medications: A treatment option for a system in need?How should dermatologists feel about direct-to-consumer online companies compounding prescription formulations? Read from three experts on the topic in this article.
Latest:
DTC compounded medications: A treatment option for a system in need?How should dermatologists feel about direct-to-consumer online companies compounding prescription formulations? Read from three experts on the topic in this article.
Latest:
Spotlight on Dermira and the QBREXZA storyHans Hofland, Ph.D, and Dr. Steve Xu shine a spotlight on Dermira and its novel topical medicine indicated for primary axillary hyperhidrosis in patients 9 years of age and older.
Latest:
A successful ownership transitionTodd Petersen, CEO of VitalSkin Dermatology, discusses the last part of your transition journey – ensuring a smooth, successful transition for you, your team and your patients.
Latest:
Mind-body therapies effective for skin disordersCarol Soutor, M.D., writes about efficacy and safety of mind-body therapies for the treatment of various skin conditions.
Latest:
Advances in Itch: Brian S. Kim, MD, Shares Insights and Treatment TipsKim, who received the Marion B. Sulzberger Award at the 2024 American Academy of Dermatology Annual Meeting, discussed itch research an implications for clinical practice.
Latest:
Nuogen Pharma: Innovation in the fight against itchNuogen Pharma’s mission is to deliver the first FDA-approved anti-itch medication for chronic pruritus of unknown origin (CPUO) and other chronic itch conditions.
Latest:
Practicing dermatology in the time of COVID-19Read one New York physician's insights on practice survival and patient care during the pandemic.
Latest:
CVS Removes Biosimilars From Drug ListOne notable change: CVS Caremark has removed the Humira biosimilar Amjevita and now prefers Hyrimoz and an unbranded biosimilar.
Latest:
Think Globally to Combat AcneTake a world tour of the global game-changing advances and home-grown success strategies dermatologists in the United States and abroad are using to tackle the challenges of acne.
Latest:
Atopic Dermatitis Remains Controlled Even After Reduction of Dupilumab DosePatients with persistently controlled atopic dermatitis who had their doses reduced were able to maintain their low disease activity.
Latest:
Clinician and Patient Perspective: Tapinarof Cream for Plaque PsoriasisMona Shahriari, MD, and a plaque psoriasis patient provide insights into the mechanism of action and benefits of tapinarof cream 1% as a nonsteroidal topical.
Latest:
Take-Home Pearls on the Management of Plaque PsoriasisAlexa Hetzel, MS, PA-C; Jennifer Conner, MPAS, PA-C; Terry Faleye, MPAS, PA-C; Laura Bush, DMSc, PA-C; and Lakshi Aldredge, MSN, ANP-BC, share take-home messages regarding the treatment of patients with plaque psoriasis, highlighting listening to and educating patients.
Latest:
Saving the World Through Pharmaceutical InnovationThe COVID-19 vaccine, and the speed at which it was developed, is the medical breakthrough of our lifetimes.
Latest:
Doris Day, MD, Discusses Primary Axillary Hyperhidrosis and Brella SweatControl PatchBrella received FDA clearance last week for improving excessive underarm sweating.
Latest:
Navigating Skin Aging Across Diverse Tones: Tailored Approaches and Cultural AwarenessAn expert in dermatology discusses the intricacies of addressing anti-aging concerns in patients with diverse skin tones, emphasizing the importance of tailoring management to meet their unique needs, understanding the underlying mechanisms of aging, and appreciating the cultural nuances within patient populations.
Latest:
4 Key Tools to Protect Personal and Practice AssetsDiscover why exempt assets, tenancy by the entirety, limited liability companies, and trusts can be key tools in finance management.
Latest:
CBP/β-catenin Antagonists: A Safe and Novel Approach for Skin Rejuvenation and AgingTake a look at this overview of the top 5 considerations to show how CBP/β-catenin antagonists can be utilized for skin rejuvenation and anti-aging by enhancing Wnt/p300/β-catenin transcription.
